2.
Factors | Noninvasive cancer group (n=69) | Invasive cancer group (n=60) | X2/t | P |
Gender | 1.087 | 0.297 | ||
Male | 35(50.7%) | 24(40.0%) | ||
Female | 34(49.3%) | 36(60.0%) | ||
Age(yr) | 58.48±8.23 | 60.97±8.98 | 0.330 | 0.567 |
pG category | 13.278 | 0.001 | ||
G1 | 38(55.1%) | 16(26.7%) | ||
G2 | 25(36.2%) | 41(68.3%) | ||
G3 | 6(8.7%) | 3(5.0%) | ||
Solid tumor size (mm) | 53.04 | < 0.001 | ||
≤9.4 | 59(85.5%) | 13(21.7%) | ||
> 9.4 | 10(14.5%) | 47(78.3%) | ||
Tumor size (mm) | 37.91 | < 0.001 | ||
≤15.3 | 62(89.9%) | 23(38.3%) | ||
> 15.3 | 7(10.1%) | 37(61.7%) | ||
C/T ratio (%) | 39.18 | < 0.001 | ||
≤47.5 | 60(87.0%) | 20(33.3%) | ||
> 47.5 | 9(13.0%) | 40(66.7%) | ||
m-CT value (HU) | 58.45 | < 0.001 | ||
≤-469.0 | 61(88.4%) | 13(21.7) | ||
> -469.0 | 8(11.6%) | 47(78.3) | ||
Max CT value (HU) | 50.25 | < 0.001 | ||
≤-35.0 | 51(73.9%) | 7(11.7%) | ||
> -35.0 | 18(26.1%) | 53(88.3%) |